We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $171B
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
Cap. Flow
+$6.93B
Cap. Flow %
4.05%
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133

Sector Composition

Rank Sector Weight
1 Miscellaneous 73.8%
2 Technology 9.57%
3 Financials 3.79%
4 Industrials 2.49%
5 Healthcare 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMAO icon
2951
Farmers & Merchants Bancorp
FMAO
$486M
$678K ﹤0.01%
+22,185
New +$613K
SFST icon
2952
Southern First Bancshares
SFST
$603M
$677K ﹤0.01%
11,080
+6,541
+144% +$377K
ETY icon
2953
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.3B
$675K ﹤0.01%
46,444
+1,457
+3% +$21.3K
INVX
2954
Innovex International
INVX
$2.1B
$674K ﹤0.01%
27,188
+3,598
+15% +$97.8K
SHLD icon
2955
Global X Defense Tech ETF
SHLD
$6.97B
$674K ﹤0.01%
11,286
+2,908
+35% +$194K
PWRD
2956
TCW Transform Systems ETF
PWRD
$1.5B
$672K ﹤0.01%
+5,469
New +$611K
ACVF icon
2957
American Conservative Values ETF
ACVF
$155M
$672K ﹤0.01%
12,331
APEI icon
2958
American Public Education
APEI
$830M
$671K ﹤0.01%
12,500
+1,416
+13% +$77.8K
USCI icon
2959
US Commodity Index
USCI
$403M
$671K ﹤0.01%
7,239
-987
-12% -$96K
CADL icon
2960
Candel Therapeutics
CADL
$978M
$670K ﹤0.01%
65,088
+33,690
+107% +$254K
AG icon
2961
First Majestic Silver
AG
$10.3B
$670K ﹤0.01%
39,508
+7,765
+24% +$154K
IBMR icon
2962
iShares iBonds Dec 2029 Term Muni Bond ETF
IBMR
$481M
$670K ﹤0.01%
26,384
-6,243
-19% -$158K
AKR icon
2963
Acadia Realty Trust
AKR
$2.79B
$668K ﹤0.01%
31,960
+9,192
+40% +$197K
VCEL icon
2964
Vericel Corp
VCEL
$2.06B
$666K ﹤0.01%
14,977
+7,199
+93% +$259K
OPFI icon
2965
OppFi
OPFI
$632M
$666K ﹤0.01%
+67,083
New +$581K
UFPT icon
2966
UFP Technologies
UFPT
$2.24B
$664K ﹤0.01%
2,503
+1,426
+132% +$310K
ALT icon
2967
Altimmune
ALT
$665M
$664K ﹤0.01%
218,281
+179,052
+456% +$535K
BCAX
2968
Bicara Therapeutics
BCAX
$1.53B
$663K ﹤0.01%
22,327
+511
+2% +$11.4K
SDOG icon
2969
ALPS Sector Dividend Dogs ETF
SDOG
$1.45B
$663K ﹤0.01%
9,716
+853
+10% +$57.2K
SHYM
2970
iShares Short Duration High Yield Muni Active ETF
SHYM
$821M
$661K ﹤0.01%
29,421
-7,142
-20% -$159K
LIT icon
2971
Global X Lithium & Battery Tech ETF
LIT
$1.59B
$660K ﹤0.01%
8,437
+562
+7% +$46.5K
PSFE icon
2972
Paysafe
PSFE
$350M
$659K ﹤0.01%
88,159
-41,752
-32% -$327K
NGVT icon
2973
Ingevity
NGVT
$2.43B
$658K ﹤0.01%
8,816
+2,656
+43% +$191K
RXT icon
2974
Rackspace Technology
RXT
$813M
$658K ﹤0.01%
100,794
-55,076
-35% -$215K
CBL
2975
CBL Properties
CBL
$1.7B
$657K ﹤0.01%
12,376
+990
+9% +$45.8K

Similar funds

Creative Planning's Q2 2026 Portfolio in Review

As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.

  • Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
  • Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
  • Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
  • Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
  • Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
  • Creative Planning opened 337 new positions and closed 133 in Q2 2026.
  • Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.